Contact Congress about H.R. 5343: Ensuring Patient Access to Critical Breakthrough Products Act

Medicare would cover some FDA breakthrough medical devices for up to four years while longer-term decisions are made. The bill sets deadlines, safety checks, reports to Congress, and funding for the program.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Ensuring Patient Access to Critical Breakthrough Products Act is a House bill in committee. The latest recorded action: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Latest action on H.R. 5343: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Who this affects: This bill mainly affects Medicare patients who may need new medical devices, especially older adults and people with disabilities. It also affects medical device makers because it gives them a clearer way to seek early Medicare coverage. Doctors, hospitals, and other providers could use some devices sooner, but they may face billing review if their use looks unusual. The Centers for Medicare & Medicaid Services, the federal agency that runs Medicare, would have new duties and reports to manage.

Why this matters: Medicare patients can wait for payment decisions even after the FDA allows a new device on the market. This bill would shorten that wait for some breakthrough devices by giving them temporary coverage. That could help patients who cannot afford the device without Medicare payment. It could also help companies plan studies and bring products to market. The effect on Medicare spending and patient health would depend on how many devices qualify and how well they work in real care.

Key provisions in H.R. 5343

• The bill creates a new Medicare label called a “breakthrough device.” The device must already have FDA breakthrough priority review under the federal law that governs medical devices, drugs, and food safety.
• Each approved breakthrough device would get four years of temporary Medicare coverage. The clock starts when the Secretary of Health and Human Services gives the Medicare breakthrough label.
• A device cleared through the FDA’s 510(k) process would need real patient data to qualify. That data must include Medicare beneficiaries, not only lab or bench testing.
• Medicare would cover the device only when doctors use it the way the FDA approved. The use must also match the condition or purpose that got FDA breakthrough priority review.
• The Secretary could deny or limit coverage during the four-year period. This could happen if clinical data show the device’s risks are too high compared with its possible benefits for Medicare patients.

How Modern Action helps you take action on H.R. 5343

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 5343

What is H.R. 5343?

Medicare would cover some FDA breakthrough medical devices for up to four years while longer-term decisions are made. The bill sets deadlines, safety checks, reports to Congress, and funding for the program.

How do I support or oppose H.R. 5343?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 5343?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 5343 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.